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Chronic myelocytic leukemia (CML)' is a clonal pluripotent stem cell disease,
clinically divided into a chronic phase of a median duration of ^-4 yr, followed
by an acute phase (blast crisis) lasting for few months (1) . Cytogenetic hallmark
of most (95%) CML cases is the presence of the Philadelphia (Ph) chromosome,
resulting from a reciprocal translocation between chromosomes 9 and 22 (2, 3) .
Molecular analyses established that, in leukemic cells of all Ph' CML patients,
the c-abl oncogene is transferred from chromosome 9 into the breakpoint cluster
region (bcr) on chromosome 22 (4, 5) ; this area is part of a gene of as-yet-
unknown function, the bcr gene, of which the coding regions are spread over at
least 70 kb, including the bcr and exons 5' and 3' to it (6-8) . This genomic
rearrangement on the Ph-chromosome results in the transcription of a chimeric
8.5 kb bcr/c-abl RNA species, which represents mRNA for an altered c-abl
protein that differs from its normal counterpart in a higher associated tyrosine
kinase activity (8-12) .
Herein, we report on a Ph' CML patient cytogenetically characterized by the
appearance ofasecondPhchromosome during blast crisis . Southern blot analyses
and in situ hybridization studies suggested a deletion of rearranged 5' bcr and c-
abl sequences in acute phase of this case . Northern blots of blastic cells detect
normal bcr and abl RNA species instead of the fused 8.5 kb transcript usually
observed in Ph' CML. These data may indicate that the altered abl protein is of
subordinate importance for the maintenance of the leukemic state once Ph'
CML has entered blast crisis .
Materials and Methods
Patient.
￿
CML was diagnosed in a 49-yr-old male exhibiting a standard Philadelphia
translocation, t(9;22)(g34;ql1) . Despite initial benefit from busulfan treatment, CML
accelerated towards lymphoid blast crisis 45 mo later . Blast cells were ofT phenotypeand
genotype (T cell receptor ,0 chain gene rearrangement), and showed a second Ph chro-
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FIGURE I .
￿
Southern blot analysis of blast cell DNAs (15 ag) digested with Bgl II, electropho-
resed on a 0.7% agarose gel and hybridized to a 2 kb Bgl II/Hind III 5' bcr probe (lane a)
and to a 1 .2 kb Hind III/Bgl II 3' bcr probe (lane b) that detect 5 kb germline fragments .
mosome as the only additional chromosomal aberration ; both Phs were of similar size as
compared with the single Ph chromosome in chronic state . Combination chemotherapy
achieved a clinical remission, and the patient has been in chronic phase for 13 mo ;
cytogenetic studies performed on three occasions during the latter period revealed two
Phs in all metaphases investigated .
DNA Analysis.
￿
Bone marrow DNA (15 ug) was digested with restriction enzymes (C .
Boehringer and Soehne, Mannheim, Federal Republic of Germany), electrophoresed on
a 0.7% agarose gel, blotted, and hybridized to a 2 kb Bgl II/Hind II 5' bcr probe, a 1 .2
kb Hind III/Bgl 11 3' bcr probe, and a I kb 5' 8E bcr cDNA probe, as described (13, 18) .
A DNAs were included as mol wt standards . After hybridization, filters were washed
under high stringency (10% saline citrate, 65°C) and exposed to XAR-2 film (Eastman
Kodak Co ., Rochester, NY) for up to 3 d at -70°C with DuPont Lightning Plus
intensifying screens (DuPont Instruments, Wilmington, DE) .
RNA Analysis .
￿
RNA was isolated from bone marrow cells according to the LiCl/urea
method (17) ; poly(A)+ RNA was obtained after two passages over oligo(dT)-cellulose ; 10
jug of poly(A)+ RNA was electrophoresed on a 1 .2% agarose gel in the presence of
formaldehyde (15) . After blotting, nitrocellulose filters (Schleicher and Schuell, Dassel,
Federal Republic of Germany) were hybridized to a 0.6 kb Eco RI/Barn HI c-abl probe
or a 2 kb Bgl II/Hind 111 5' bcr probe, as described (13) . Filters were exposed to Kodak
XAR-5 film using DuPont Lightning Plus intensifying screens for up to 4 d at -70°C .
In Situ Hybridization . Chromosomes obtained from bone marrow were prepared
according to standard techniques . After RNase treatment, chromosomes were denatured
in 70% formamide in 2X SSC at 70°C for 2 min, rinsed in 2X SSC, and dehydrated . The
probe, a 1 :1 mixture of human 3' 1 .1 kb Hind III/Eco RI and 5' 0.6 kb Barn HI c-abl
plasmids (17) was labelled by nick-translation using [ sH]c1CTP and [sH]dTTP (New
England Nuclear, Boston, MA) to a sp act of 1 .2 X 10 cpm/,ug . The probe was denatured
for 5 min at 70°C at a concentration of 0.2 Ag/ml in 50% formamide in 2X SSC with
10% dextran sulfate added to the chromosomes, and hybridized for 10 h at 37°C ; slides
were rinsed in three changes of50% formamide/2X SSC at 39°C, followed by 6 h washing
in 2X SSC at room temperature, exposed to Kodak NTB2 emulsion for 12 d at 4° C,
developed, and stained with quinacrince mustard as described (13) .
Results
Southern blot analysis of leukemic cells obtained from this case during blast
crisis show a 5 kb germline band after hybridization to 5' bcr sequences (Fig . 1,
lane a) . In contrast to all Ph' CML patients investigated thus far, a rearrangedBARTRAM ET AL .
￿
139 1
FIGURE 2 .
￿
Southern blot analysis of human placenta (lanes a) and blast cell DNAs (lanes b).
15,ug DNAs were digested with Eco R1, Bam H1, or Bgl 11 as indicated, electrophoresed, and
hybridized to a 1 kb 5' 8E bcr cDNA probe .
5' bcr fragment is not visible. However, a recombination within the bcr could be
established by hybridization ofBgl 11 digests to 3' bcr sequences that are usually
transferred to chromosome 9q+ in Ph'CML (Fig . 1, lane b) . A Bgl 11 polymor-
phism as an explanation for the latter result could be ruled out, since digests
using different restriction enzymes (Bam H1, Eco R1, and Hind 111) showed a
similar pattern (datanot shown) . To investigate thepossibility that, in this patient,
the break on chromosome 22 has occurred outside the bcr region but still within
the bcr gene, we hybridized different digests of blast cell DNAs to a 1 kb cDNA
probe covering the most 5' bcr sequences known thus far (18). Again no
rearranged fragments are detected as compared with control DNAs (Fig . 2) .
These results suggested a deletion of rearranged 5' bcr sequences in blast cells .
However, the cDNA probe might not cover all chromosomal bcr sequences, and
we therefore cannot entirely rule out the possibility that a recombination took
place in such a region . Since cell samples from the chronic state of this patient
were not available for Southern blot analysis, we decided to perform in situ1392
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TABLE I
Results ofIn Situ Hybridization to c-abl Probes
Grains were counted on complete, well-spread metaphases . Number of
grains expected wasdetermined according to DNA content (16) .
* On two Ph chromosomes .
FIGURE 3 .
￿
Distribution of silver grains on relevant chromosomes obtained from chronic
phase (A) and blast crisis (B) of the CML patient hybridized in situ to c-abl probes (see Table
1) .
hybridization studies ofc-abl sequences to metaphases obtained from both states,
to investigate a possible concurrent deletion of this oncogene .
Distribution of 104 silver grains obtained from analysis of 21 metaphases of
chronic phase was uniform and at random on all chromosomes except specific
signals (p<0.01) on chromosomes 9 and 22q- (Table I and Fig . 3A) . However,
in situ hybridization on c-abl sequences to 49 metaphases obtained from blast
crisis showed a significant grain accumulation (p < 0.01) only on chromosome
9, while distribution of silver grains on both Phs and all other chromosomes was
Chromosome
Chronic
Grains
observed
phase
Expected
Blast
Grains
observed
crisis
Expected
1 7 9.0 24 18 .1
2 12 8.8 14 17.7
3 4 7.3 12 14.6
4 9 7.0 7 14.0
5 6 6.7 11 13.4
6 2 6.3 6 12.6
7 5 5.8 10 11 .6
8 2 5.3 8 6.5
9 13 2.5 34 5.0
9q+ 5 3 .0 7 5.7
10 2 4.9 8 9.7
11 3 5 .0 6 10.0
12 0 4.9 11 9.8
13 6 3 .9 4 7.8
14 1 3 .7 5 7.5
15 2 3 .5 2 7.1
16 3 3 .2 9 6.5
17 5 3 .1 8 6.2
18 0 2 .9 5 5.9
19 1 2 .3 5 4.5
20 0 2.5 0 5.0
21 0 1 .7 1 3.4
22 3 0.9 0 1 .8
Ph 9 0.5 4* 2.2*
X 4 2.8 7 5.6
Y 0 1 .0 3 1 .9BARTRAM ET AL .
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FIGURE 4 .
￿
Northern blot analysis of poly(A)' RNA (10 Ag) obtained from blast cells of the
CMLpatient hybridized to a c-abl (lane a) and 5' bcr probe (lane b) . The position of ribosomal
28 S and 18 S RNA is indicated .
uniform (Table I and Fig . 3B). These results unequivocally demonstrated a
deletion of c-abl sequences from the blast phase Ph-chromosomes .
Finally, we performed Northern blot analyses of blastic cells . Hybridization to
c-abl and bcr sequences exhibited normal 6 and 7 kb c-abl as well as 4.5 and ^-7
kb bcr transcripts, respectively (Fig . 4) . Neither probe detected the hybrid 8 .5
kb bcrlabl RNA species usually found in Ph' CML.
Taken together, the occurrence of a bcr/c-abl rearrangement in this case
during generation of CML is deduced from the demonstration ofa c-abl onco-
gene translocation by in situ hybridization in chronic state samples and the
detection of rearranged 3' bcr sequences in Southern blots from acute state . A
deletion of recombined sequences of both genes in acute state, probably during
duplication of the Ph chromosome, is suggested by the failure to detect (a)
translocated c-abl sequences on both Phs, (b) rearranged 5' bcr sequences, and
(c) the hybrid 8.5 kb bcr/abl transcript during blast crisis .
Discussion
The involvement of c-abl and bcr sequences in the development of Ph' CML
has been deduced from (a) the consistent observation of a rearrangement ofboth
genes on the Ph chromosome in all cytogenetic subtypes of this leukemia, (b) the
concurrent detection of a novel 8.5 kb chimeric bcr/c-abl RNA transcript, and
(c) the expression of an altered p210 c-abl protein that differs from the normal
p145 counterpart as to its associated tyrosine kinase activity (4-12, 19, 20) .
However, neither the precise physiological function of the products encoded by
both genes nor the meaning of their altered versions in Ph' CML has been
elucidated as yet . Moreover, recent reports on Ph- CML characterized by a bcr
rearrangement without juxtaposition of c-abl (21), as well as Ph' ALL cases
showing a c-abl translocation to other sequences on the Ph instead of bcr (22)
may indicate that both genes could interact with other genes to generate similar
leukemic entities . Several Ph- CML patients have been observed (23, 24) that
developed the Ph during later stages of their leukemia, suggesting that acquisition1394
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of Ph is not the primary event in the generation of this disease. Other patients
with typical Ph' CML entered acute phase with blast cells lacking the Ph
chromosome, consistent with the existence of Ph- leukemic cells within the same
patient (25). Finally, glucose-6-phosphate dehydrogenase isoenzyme analysis
showed the presence of Ph- leukemic cells in Ph' CML patients (26). These data
suggest a multistep pathogenesis of CML in which the development of the
cytogenetically visible Ph chromosome, as well as the molecularly detectable
bcr/c-abl rearrangement is a second event in this process.
Along this line, transition of chronic towards acute phase of Ph' CML would
represent a third step, characterized by marked differences in the biology of
leukemic cells, and associated with karyotypic evolution exhibiting additional
nonrandom chromosomal aberrations (1, 27). The detection of identical rear-
ranged bcr fragments as well as comparable levels of the 8.5 kb bcr/abl RNA
species in blast cells and chronic phase cells of the same patients also suggest that
genes other than bcr and c-abl induce this terminal shift of biological properties
within leukemic cells (9, 28, and Bartram, unpublished results).
However, the data presented here do not necessarily rule out a possible
influence of rearranged abl/bcr sequences for the course of CML blast crisis. In
this respect it seems to be noteworthy that the patient has survived the acute
phase for already >1 yr in remarkably good condition. Thus the deletion of the
rearranged abl/bcr sequences, i.e., the withdrawal of the second step on the way
to CML blast crisis, may result in the manifestation of a leukemic state that
differs from the much more aggressive blast crisis usually observed in CML.
On the other hand, the results reported here mayindicate that once a leukemic
cell has entered blast crisis, the rearranged abl/bcr sequences and their respective
protein product may have a modulating effect on the clinical course of blast
crisis, but are no longer essential for the maintenance of a leukemic state itself.
While the present case appears to be a unique in vivo model to study the necessity
of altered bcr/abl sequences in CML blast crisis, it would be of considerable
interest to investigate in vitro the effect of either antisense RNA or monoclonal
antibodies directed against altered bcr/abl sequences in leukemic cells obtained
from chronic phase of Ph' CML patients. It seems tempting to speculate that
these in vitro studies could prove a crucial function of these genes in the chronic
phase of CML, while our present investigation can only address their respective
role in blast crisis.
Summary
We report on a Ph' chronic myelocytic leukemia (CML) case, cytogenetically
characterized by the occurrence of a second Philadelphia (Ph) chromosome in
lymphoid blast crisis of T cell lineage. In situ hybridization analyses showed a
deletion of translocated c-abl sequences, present on the Ph during chronic state,
from both Ph in acute state. Moreover, Southern blot analyses of blastic cells
exhibited a rearrangement within bcr, but a deletion of 5' bcr sequences, and
Northern blots failed to detect the hybrid 8.5 kb bcr/c-abl transcript usually
observed in Ph' CML.
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